Menopause worsens ADHD symptoms, but standard assessments do not capture the depth of women’s misery.
Menopause aggravates and elevates ADHD symptoms for a staggering 97.5 percent of women with the condition, according to a survey of 600 women cited in the Journal of Psychiatric Research.1 Complaints include increased difficulty with attention, emotional regulation, and managing everyday demands – symptoms that significantly degrade quality of life yet remain largely unaddressed in midlife ADHD treatment plans.
The Adult ADHD Self-Report Scale (ASRS) – one of the standard measures for assessing common ADHD symptoms – may not fully capture how much menopause interferes with daily life because it was not specifically designed to measure changes in ADHD across hormonal transitions.
Sources indicate that while nearly all of the 600 women in the survey reported worsening ADHD symptoms during menopause, their ASRS scores were similar across different hormonal life stages. This apparent contradiction deserves attention. A woman may experience a major change in mental clarity, working memory, motivation, emotional regulation, and managing day-to-day responsibilities without necessarily showing a large change on a standard ADHD symptom checklist.
[Get This Free Download: Menopause and ADHD].
This points to a critical need for better ways to assess ADHD across the lifespan and to understand how hormonal changes may alter its presentation and impact.
According to recent reports, today, we know about ADHD in menopause thanks, largely, to women’s personal accounts. Though surveys and self-reports cannot establish cause and effect in the same way as controlled clinical trials, they are an essential starting point. They can identify patterns and raise questions that researchers need to investigate.
Sources indicate that one central question is regarding the safety and efficacy of prescribing hormone replacement therapy (HRT) and/or ADHD medication to women in perimenopause and menopause. Sadly, evidence specifically supporting combined HRT and stimulant treatment remains limited. We need well-designed studies to determine which women might benefit, what treatments are most effective, and how the medications may interact.
[Read: How Hormonal Changes Impact ADHD Symptoms in Women].
The voices of women with ADHD have brought this problem into view. Now clinicians and researchers have an opportunity – and a responsibility – to listen carefully, investigate rigorously, and translate emerging knowledge into better care.
Kathleen Nadeau, Ph.D., is the founder and clinical director of the Institute for Lifespan ADHD Training.
ADDITUDE IS HUMAN Artificial intelligence does not create or edit any written content published by ADDitude. Our editorial team is 100% human, and our mission is simple: listen to and serve our readers with hand-crafted, expert-informed resources. To support ADDitude, please consider subscribing. Your readership and support help make our commitment possible. Thank you.
1 Osianlis, E., Thomas, E. H. X., Li, Q., Bellgrove, M., May, T., Chapman, D., Kulkarni, J., & Gurvich, C. (2026). ADHD in females: Survey findings on symptoms across hormonal life stages. Journal of psychiatric research, 193, 208–215. https://doi.org/10.1016/j.jpsychires.2025.11.035.
It has been revealed that it appears JavaScript is disabled in your browser. Please enable JavaScript and refresh the page in order to complete this form.
